Explore All 375 Stake Purchase Information Technology Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | July 1, 2014 |
| Target | Zego |
| Sector | Information Technology |
| Investor(s) |
Francisco Partners
Mainsail Partners |
| Deal Type | Stake Purchase |
| Advisor(s) | Raymond James - Investment Banking (Financial) |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 45.0B USD |
| Size | Mega |
| Type | Sector Focused |
Francisco Partners is a private equity firm focused exclusively on investments in technology and technology-enabled services. Specific areas of interest include semiconductors, capital equipment, electronics components, systems and manufacturing, IT services and business process outsourcing, communications, security and enterprise applications, and infrastructure software. Prospective investment situations include divisional buyouts, growth equity financings, acquisitions of private companies, sponsored mergers and acquisitions, and take-privates. Francisco Partners looks for opportunities where it can commit a minimum of $100 million per investment. Francisco Partners was formed in 1999 and is based in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 64 of 160 |
| Sector: Information Technology | 14 of 30 |
| Type: Stake Purchase | 2 of 5 |
| State: California | 17 of 33 |
| Country: United States | 51 of 134 |
| Year: 2014 | 3 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-06-05 |
Masternaut UK
Aberford, United Kingdom Masternaut UK Ltd. is a designer and delivers SaaS solutions for managing the mobile workforce that enable customers and partners to achieve evolutionary step-changes in their performance and service delivery. Formed through the combination of established telematics providers, Cybit and Masternaut, the new Masternaut boasts the broadest range of telematics products, services and R&D capability in Europe. Masternaut UK Ltd. was founded in and is based in Aberford, United Kingdom. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-01 |
Vendavo
Denver, Colorado, United States Vendavo provides flexible software solutions that assist manufacturers and distributors with managing, pricing and structuring contractual relationships. Vendavo Advantage is a complete, enterprise-class solution combining all aspects of deal pricing, negotiating, analysis and monitoring. Vendavo was founded in 1998 and is based in Denver, Colorado. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 2.2B USD |
| Size | Large |
| Type | Sector Focused |
Mainsail Partners is a private equity firm that principally targets investments in North American bootstrapped software companies with proven business models and long-term growth potential. Mainsail looks commit $10 to $75 million of equity capital per transaction in businesses generating annual revenues of $4 to $25 million. Mainsail Partners was formed in 2003 and is based in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 10 of 51 |
| Sector: Information Technology | 2 of 5 |
| Type: Stake Purchase | 1 of 1 |
| State: California | 4 of 9 |
| Country: United States | 10 of 50 |
| Year: 2014 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-07 |
nCourt
Woodstock, Georgia, United States nCourt is an independent provider of payment solutions for courts and government entities. The Company serves thousands of government agencies across the United States by providing payment options for traffic citations, property taxes, utilities and court fines, among other services. nCourt was founded in 2002 and is based in Woodstock, Georgia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-02 |
Novus Biologicals
Littleton, Colorado, United States Novus Biologicals LLC, is an e-commerce and life sciences company that develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Since 1996, Novus Biologicals has partnered with scientific researchers and third-party providers to develop a portfolio of more than 100,000 products. These research tools provide investigators with high-quality antibodies, proteins, kits and RNAi for the study of protein functions in disease in the key fields of cancer, neuroscience, and metabolic disorders. |
Sell | $60M |
